According to the research report, the global nicotinamide adenine dinucleotide (NAD) market was valued at USD 535.53 million in 2022 and is expected to reach USD 1,722.11 million by 2032, to grow at a CAGR of 12.41% during the forecast period.
Nicotinamide Adenine Dinucleotide Market to Dominate Worldwide by 2032